Wehkamp J - Search Results

1

A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease.

Schölmerich J, Fellermann K, Seibold FW, Rogler G, Langhorst J, Howaldt S, Novacek G, Petersen AM, Bachmann O, Matthes H, Hesselbarth N, Teich N, Wehkamp J, Klaus J, Ott C, Dilger K, Greinwald R, Mueller R; International TRUST-2 Study Group. Schölmerich J, et al. Among authors: wehkamp j. J Crohns Colitis. 2017 Apr 1;11(4):390-399. doi: 10.1093/ecco-jcc/jjw184. J Crohns Colitis. 2017. PMID: 27707789 Free PMC article. Clinical Trial.

2

Crohn's disease: a defensin deficiency syndrome?

Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Fellermann K, et al. Among authors: wehkamp j. Eur J Gastroenterol Hepatol. 2003 Jun;15(6):627-34. doi: 10.1097/00042737-200306000-00008. Eur J Gastroenterol Hepatol. 2003. PMID: 12840673 Review.

3

Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn's Disease.

Jaeger SU, Schaeffeler E, Winter S, Tremmel R, Schölmerich J, Malek N, Stange EF, Schwab M, Wehkamp J. Jaeger SU, et al. Among authors: wehkamp j. Front Pharmacol. 2018 Jul 16;9:764. doi: 10.3389/fphar.2018.00764. eCollection 2018. Front Pharmacol. 2018. PMID: 30061834 Free PMC article.

4

Crohn's disease--defect in innate defence.

Gersemann M, Wehkamp J, Fellermann K, Stange EF. Gersemann M, et al. Among authors: wehkamp j. World J Gastroenterol. 2008 Sep 28;14(36):5499-503. doi: 10.3748/wjg.14.5499. World J Gastroenterol. 2008. PMID: 18810765 Free PMC article. Review.

5

Human defensins in Crohn's disease.

Wehkamp J, Fellermann K, Stange EF. Wehkamp J, et al. Chem Immunol Allergy. 2005;86:42-54. doi: 10.1159/000086672. Chem Immunol Allergy. 2005. PMID: 15976487 Review.

6

Reduced mucosal antimicrobial activity in Crohn's disease of the colon.

Nuding S, Fellermann K, Wehkamp J, Stange EF. Nuding S, et al. Among authors: wehkamp j. Gut. 2007 Sep;56(9):1240-7. doi: 10.1136/gut.2006.118646. Epub 2007 Apr 24. Gut. 2007. PMID: 17456510 Free PMC article.

7

Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.

Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K, Schroeder JM, Stange EF. Wehkamp J, et al. Inflamm Bowel Dis. 2003 Jul;9(4):215-23. doi: 10.1097/00054725-200307000-00001. Inflamm Bowel Dis. 2003. PMID: 12902844

8

Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.

Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J. Schmid M, et al. Among authors: wehkamp j. J Leukoc Biol. 2007 Apr;81(4):907-15. doi: 10.1189/jlb.0906581. Epub 2007 Jan 2. J Leukoc Biol. 2007. PMID: 17200145

9

Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

Rieder F, Karrasch T, Ben-Horin S, Schirbel A, Ehehalt R, Wehkamp J, de Haar C, Velin D, Latella G, Scaldaferri F, Rogler G, Higgins P, Sans M. Rieder F, et al. Among authors: wehkamp j. J Crohns Colitis. 2012 Apr;6(3):373-85. doi: 10.1016/j.crohns.2011.11.009. Epub 2011 Dec 11. J Crohns Colitis. 2012. PMID: 22405177 Free article. Review.

10

Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.

Herrlinger KR, Dittmann R, Weitz G, Wehkamp J, Ludwig D, Schwab M, Stange EF, Fellermann K. Herrlinger KR, et al. Among authors: wehkamp j. Inflamm Bowel Dis. 2004 May;10(3):229-33. doi: 10.1097/00054725-200405000-00008. Inflamm Bowel Dis. 2004. PMID: 15290916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page